Ophthalmic Drug Delivery Latest Development
The global market for ophthalmic eye droppers is expected to grow due to the rising rates of eye diseases such as glaucoma, dry eye disease, and age-related macular degeneration. Various packaging advancements for eye drops have occurred over time. Currently, manufacturers are exploring multidose bottles that safely dispense unpreserved drops without contamination. Regulatory approvals for these products have become more common, emphasizing the importance of maintaining sterility. There are opportunities for innovation, particularly in eco-design, focusing on reducing plastic use and water consumption; and in digital technology, utilizing sensors, AI and telemedicine to improve patient adherence and care.
Future innovations may include alternative delivery methods to improve treatment efficacy and management of eye diseases. This article aims to discuss the Ophthalmic Drug Delivery Latest Development.